As per the latest update, the company’s shares are trading at Rs 1,353 in the unlisted markets. This indicates a premium of nearly 28% over the upper price band. The company has fixed the price band ...

Corona Remedies’ shares made a strong debut on the stock market, gaining 36.72 per cent over its IPO price. The pharma company’s shares were listed at Rs 1,452 on the NSE, up Rs 390 from the upper ...

The Rs 655.37-crore initial public offering (IPO) of Crorona Remedies mobilised Rs 195 crore from anchor investors.

Ahead of the Dalal Street debut, the grey market premium is indicating a robust listing gain of around 32 per cent, according to the platforms that track unlisted market space.

Track Corona Remedies share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit & ...

Corona Remedies made a strong market debut on December 15, with shares listed at ₹1,461 on NSE and ₹1,452 on BSE, reflecting ...

Corona Remedies made a remarkable debut on the stock market, opening with a significant premium. The company's Rs 655-crore IPO was massively oversubscribed, attracting strong interest from ...

At a price band of Rs 1,008–1,062 per share and a lot size of 120 shares, the Rs 655.37-crore IPO triggered massive interest, drawing 62.65 crore bids against just 45.72 lakh shares available, based ...

Shares of Corona Remedies were currently trading at Rs 1,465.55 at 10:20 IST on the BSE, representing a premium of 38% as compared with the issue price of Rs 1,062.

The share allotments for Corona Remedies IPO will likely be finalised by today, December 11. IPO applicants can check their allotment status on the official websites of BSE and NSE, as well as the ...